Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Orphan drug benefit scores in Germany are influenced by phase III data and lack of alternatives, but not linked to price or discounts.

Cataract surgery in Europe varies in frequency and cost between countries.

The document concludes that PK/PD modeling is important for determining the safe and effective dosages of drugs.

Using more low-cost and generic drugs could save Medicare Part D a lot of money.

Drug repurposing can speed up and reduce costs in drug discovery, especially for cancer treatment.

The conclusion is that combining social and cultural factors with pharmaceutical research could improve our understanding of how drugs work.

Adopting the Mark Cuban Cost Plus Drug Company pricing model could save Medicare about $1.29 billion on urological drugs.

Qianliekang and liuweidihuangwan are cheaper for BPH treatment than finasteride and tamsulosin.

Drug repurposing offers faster, cheaper drug development but faces challenges like safety, ethics, and funding.

Drug repurposing can be cost-effective but needs more testing for safety and effectiveness.

Risk analysis is important for safely adjusting pharmaceutical formulas while maintaining their quality and effectiveness.

Using Mark Cuban Cost Plus Drug Company can save money on men's health medications compared to Medicare.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Government action is needed to address high prescription drug prices.

The same drug is priced differently based on its use.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

Biosimilars lower costs but don't significantly improve access.

UK courts and the European Patent Office are now more open to granting patents for new dosage regimes.

Proscar and Propecia, two drugs with the same ingredient but different dosages, have different prices, showing price discrimination in the pharmaceutical industry.

Redefining drug dosages is crucial when repurposing them for new uses.

Old drugs can be used for new treatments, saving time and money, but there are challenges like needing more evidence and legal concerns.

The document suggests reevaluating the patent system to ensure public benefits from pharmaceutical privileges and to encourage more significant innovations.

CPDC offers significant cost savings on men's health medications compared to Medicare and GoodRx.

Adding baricitinib will increase costs but offers more treatment options for alopecia areata.

Using existing drugs for new treatments is cost-effective and safer.

The review concludes that pharmacists should clearly define their product as more than medication, including their knowledge and services, to effectively communicate their value.

Data-driven methods can effectively identify existing drugs for new uses, especially in cancer, infections, and respiratory diseases.

The conclusion is that the increasing use of drugs for lifestyle reasons is a complex issue influenced by corporate profit, consumer behavior, and the medicalization of everyday life, with potential negative effects on personal well-being.

Public health decisions should rely on independent trials, not biased literature.